 | • レポートコード：GIR201112815 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ケトロラックトロメタミンの世界市場を調査対象にし、ケトロラックトロメタミンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（注射、眼科、鼻、経口錠剤）、用途別分析（痛み短期治療、眼科手術）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer、West Ward Pharmaceuticals、Allergan、Omeros Corporation、Mylan、Egalet US Inc.、Apotex、Teva、Dr. Reddy’s Laboratories、Fresenius Kabi、Sun Pharmaceutical、Sandoz、Sagent Pharmaceuticals、Akorn、Amphastar Pharmaceuticals、Aurobindo Pharma、Gland Pharma Limited ・メーカー別販売量、売上、市場シェア ・ケトロラックトロメタミンの地域別市場分析 ・ケトロラックトロメタミンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ケトロラックトロメタミンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ケトロラックトロメタミンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ケトロラックトロメタミンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ケトロラックトロメタミンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ケトロラックトロメタミンの種類別市場規模2015-2020：注射、眼科、鼻、経口錠剤 ・ケトロラックトロメタミンの用途別市場規模2015-2020：痛み短期治療、眼科手術 ・ケトロラックトロメタミンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Ketorolac Tromethamine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ketorolac Tromethamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ketorolac Tromethamine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ketorolac Tromethamine market has been segmented into
Injection
Ophthalmic
Nasal
Oral tablet
By Application, Ketorolac Tromethamine has been segmented into:
Short-term treatment of pain
Ophthalmic Surgery
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ketorolac Tromethamine market presented in the report. This section sheds light on the sales growth of different regional and country-level Ketorolac Tromethamine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ketorolac Tromethamine market.
The report offers in-depth assessment of the growth and other aspects of the Ketorolac Tromethamine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ketorolac Tromethamine Market Share Analysis
Ketorolac Tromethamine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ketorolac Tromethamine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ketorolac Tromethamine sales, revenue and market share for each player covered in this report.
The major players covered in Ketorolac Tromethamine are:
Pfizer
West Ward Pharmaceuticals
Allergan
Omeros Corporation
Mylan
Egalet US Inc.
Apotex
Teva
Dr. Reddy’s Laboratories
Fresenius Kabi
Sun Pharmaceutical
Sandoz
Sagent Pharmaceuticals
Akorn
Amphastar Pharmaceuticals
Aurobindo Pharma
Gland Pharma Limited
Among other players domestic and global, Ketorolac Tromethamine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketorolac Tromethamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ketorolac Tromethamine, with price, sales, revenue and global market share of Ketorolac Tromethamine in 2018 and 2019.
Chapter 3, the Ketorolac Tromethamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketorolac Tromethamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ketorolac Tromethamine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ketorolac Tromethamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ketorolac Tromethamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ketorolac Tromethamine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Ophthalmic
1.2.4 Nasal
1.2.5 Oral tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Ketorolac Tromethamine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Short-term treatment of pain
1.3.3 Ophthalmic Surgery
1.4 Overview of Global Ketorolac Tromethamine Market
1.4.1 Global Ketorolac Tromethamine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 West Ward Pharmaceuticals
2.2.1 West Ward Pharmaceuticals Details
2.2.2 West Ward Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 West Ward Pharmaceuticals SWOT Analysis
2.2.4 West Ward Pharmaceuticals Product and Services
2.2.5 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Allergan SWOT Analysis
2.3.4 Allergan Product and Services
2.3.5 Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Omeros Corporation
2.4.1 Omeros Corporation Details
2.4.2 Omeros Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Omeros Corporation SWOT Analysis
2.4.4 Omeros Corporation Product and Services
2.4.5 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Egalet US Inc.
2.6.1 Egalet US Inc. Details
2.6.2 Egalet US Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Egalet US Inc. SWOT Analysis
2.6.4 Egalet US Inc. Product and Services
2.6.5 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Apotex SWOT Analysis
2.7.4 Apotex Product and Services
2.7.5 Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva SWOT Analysis
2.8.4 Teva Product and Services
2.8.5 Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dr. Reddy’s Laboratories
2.9.1 Dr. Reddy’s Laboratories Details
2.9.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Dr. Reddy’s Laboratories SWOT Analysis
2.9.4 Dr. Reddy’s Laboratories Product and Services
2.9.5 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fresenius Kabi
2.10.1 Fresenius Kabi Details
2.10.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fresenius Kabi SWOT Analysis
2.10.4 Fresenius Kabi Product and Services
2.10.5 Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sun Pharmaceutical
2.11.1 Sun Pharmaceutical Details
2.11.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sun Pharmaceutical SWOT Analysis
2.11.4 Sun Pharmaceutical Product and Services
2.11.5 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sandoz
2.12.1 Sandoz Details
2.12.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sandoz SWOT Analysis
2.12.4 Sandoz Product and Services
2.12.5 Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sagent Pharmaceuticals
2.13.1 Sagent Pharmaceuticals Details
2.13.2 Sagent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sagent Pharmaceuticals SWOT Analysis
2.13.4 Sagent Pharmaceuticals Product and Services
2.13.5 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Akorn SWOT Analysis
2.14.4 Akorn Product and Services
2.14.5 Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Amphastar Pharmaceuticals
2.15.1 Amphastar Pharmaceuticals Details
2.15.2 Amphastar Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Amphastar Pharmaceuticals SWOT Analysis
2.15.4 Amphastar Pharmaceuticals Product and Services
2.15.5 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aurobindo Pharma
2.16.1 Aurobindo Pharma Details
2.16.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Aurobindo Pharma SWOT Analysis
2.16.4 Aurobindo Pharma Product and Services
2.16.5 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Gland Pharma Limited
2.17.1 Gland Pharma Limited Details
2.17.2 Gland Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Gland Pharma Limited SWOT Analysis
2.17.4 Gland Pharma Limited Product and Services
2.17.5 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ketorolac Tromethamine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ketorolac Tromethamine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ketorolac Tromethamine Manufacturer Market Share in 2019
3.3.2 Top 6 Ketorolac Tromethamine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ketorolac Tromethamine Sales, Revenue and Market Share by Regions
4.1.1 Global Ketorolac Tromethamine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ketorolac Tromethamine Revenue and Market Share by Regions (2015-2020)
4.2 North America Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
4.3 Europe Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
4.5 South America Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ketorolac Tromethamine Sales, Revenue and Market Share by Country
5.1.1 North America Ketorolac Tromethamine Sales and Market Share by Country (2015-2020)
5.1.2 North America Ketorolac Tromethamine Revenue and Market Share by Country (2015-2020)
5.2 United States Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
5.3 Canada Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
5.4 Mexico Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ketorolac Tromethamine Sales, Revenue and Market Share by Country
6.1.1 Europe Ketorolac Tromethamine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ketorolac Tromethamine Revenue and Market Share by Country (2015-2020)
6.2 Germany Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
6.3 UK Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
6.4 France Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
6.5 Russia Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
6.6 Italy Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ketorolac Tromethamine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ketorolac Tromethamine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ketorolac Tromethamine Revenue and Market Share by Regions (2015-2020)
7.2 China Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7.3 Japan Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7.4 Korea Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7.5 India Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
7.7 Australia Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ketorolac Tromethamine Sales, Revenue and Market Share by Country
8.1.1 South America Ketorolac Tromethamine Sales and Market Share by Country (2015-2020)
8.1.2 South America Ketorolac Tromethamine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
8.3 Argentina Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ketorolac Tromethamine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ketorolac Tromethamine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ketorolac Tromethamine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
9.3 Turkey Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
9.4 Egypt Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
9.5 South Africa Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ketorolac Tromethamine Sales and Market Share by Type (2015-2020)
10.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2015-2020)
10.3 Global Ketorolac Tromethamine Price by Type (2015-2020)
11 Global Ketorolac Tromethamine Market Segment by Application
11.1 Global Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
11.2 Global Ketorolac Tromethamine Revenue Market Share by Application (2015-2020)
11.3 Global Ketorolac Tromethamine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ketorolac Tromethamine Sales, Revenue and Growth Rate (2021-2025)
12.2 Ketorolac Tromethamine Market Forecast by Regions (2021-2025)
12.2.1 North America Ketorolac Tromethamine Market Forecast (2021-2025)
12.2.2 Europe Ketorolac Tromethamine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ketorolac Tromethamine Market Forecast (2021-2025)
12.2.4 South America Ketorolac Tromethamine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ketorolac Tromethamine Market Forecast (2021-2025)
12.3 Ketorolac Tromethamine Market Forecast by Type (2021-2025)
12.3.1 Global Ketorolac Tromethamine Sales Forecast by Type (2021-2025)
12.3.2 Global Ketorolac Tromethamine Market Share Forecast by Type (2021-2025)
12.4 Ketorolac Tromethamine Market Forecast by Application (2021-2025)
12.4.1 Global Ketorolac Tromethamine Sales Forecast by Application (2021-2025)
12.4.2 Global Ketorolac Tromethamine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ketorolac Tromethamine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ketorolac Tromethamine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ketorolac Tromethamine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Ketorolac Tromethamine Major Business
Table 9. Pfizer Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Ketorolac Tromethamine Product and Services
Table 12. Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. West Ward Pharmaceuticals Ketorolac Tromethamine Major Business
Table 15. West Ward Pharmaceuticals Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 16. West Ward Pharmaceuticals SWOT Analysis
Table 17. West Ward Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 18. West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Allergan Basic Information, Manufacturing Base and Competitors
Table 20. Allergan Ketorolac Tromethamine Major Business
Table 21. Allergan Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 22. Allergan SWOT Analysis
Table 23. Allergan Ketorolac Tromethamine Product and Services
Table 24. Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 26. Omeros Corporation Ketorolac Tromethamine Major Business
Table 27. Omeros Corporation Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 28. Omeros Corporation SWOT Analysis
Table 29. Omeros Corporation Ketorolac Tromethamine Product and Services
Table 30. Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Ketorolac Tromethamine Major Business
Table 33. Mylan Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 34. Mylan SWOT Analysis
Table 35. Mylan Ketorolac Tromethamine Product and Services
Table 36. Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Egalet US Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Egalet US Inc. Ketorolac Tromethamine Major Business
Table 39. Egalet US Inc. Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 40. Egalet US Inc. SWOT Analysis
Table 41. Egalet US Inc. Ketorolac Tromethamine Product and Services
Table 42. Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Apotex Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Ketorolac Tromethamine Major Business
Table 45. Apotex Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 46. Apotex SWOT Analysis
Table 47. Apotex Ketorolac Tromethamine Product and Services
Table 48. Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Basic Information, Manufacturing Base and Competitors
Table 50. Teva Ketorolac Tromethamine Major Business
Table 51. Teva Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 52. Teva SWOT Analysis
Table 53. Teva Ketorolac Tromethamine Product and Services
Table 54. Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 56. Dr. Reddy’s Laboratories Ketorolac Tromethamine Major Business
Table 57. Dr. Reddy’s Laboratories Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 58. Dr. Reddy’s Laboratories SWOT Analysis
Table 59. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product and Services
Table 60. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 62. Fresenius Kabi Ketorolac Tromethamine Major Business
Table 63. Fresenius Kabi Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 64. Fresenius Kabi SWOT Analysis
Table 65. Fresenius Kabi Ketorolac Tromethamine Product and Services
Table 66. Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Ketorolac Tromethamine Major Business
Table 69. Sun Pharmaceutical Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 70. Sun Pharmaceutical SWOT Analysis
Table 71. Sun Pharmaceutical Ketorolac Tromethamine Product and Services
Table 72. Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sandoz Basic Information, Manufacturing Base and Competitors
Table 74. Sandoz Ketorolac Tromethamine Major Business
Table 75. Sandoz Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 76. Sandoz SWOT Analysis
Table 77. Sandoz Ketorolac Tromethamine Product and Services
Table 78. Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagent Pharmaceuticals Ketorolac Tromethamine Major Business
Table 81. Sagent Pharmaceuticals Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 82. Sagent Pharmaceuticals SWOT Analysis
Table 83. Sagent Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 84. Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Akorn Basic Information, Manufacturing Base and Competitors
Table 86. Akorn Ketorolac Tromethamine Major Business
Table 87. Akorn Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 88. Akorn SWOT Analysis
Table 89. Akorn Ketorolac Tromethamine Product and Services
Table 90. Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Amphastar Pharmaceuticals Ketorolac Tromethamine Major Business
Table 93. Amphastar Pharmaceuticals Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 94. Amphastar Pharmaceuticals SWOT Analysis
Table 95. Amphastar Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 96. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Aurobindo Pharma Ketorolac Tromethamine Major Business
Table 99. Aurobindo Pharma Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 100. Aurobindo Pharma SWOT Analysis
Table 101. Aurobindo Pharma Ketorolac Tromethamine Product and Services
Table 102. Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 104. Gland Pharma Limited Ketorolac Tromethamine Major Business
Table 105. Gland Pharma Limited Ketorolac Tromethamine Total Revenue (USD Million) (2018-2019)
Table 106. Gland Pharma Limited SWOT Analysis
Table 107. Gland Pharma Limited Ketorolac Tromethamine Product and Services
Table 108. Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Ketorolac Tromethamine Sales by Manufacturer (2018-2019) (K Units)
Table 110. Global Ketorolac Tromethamine Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Ketorolac Tromethamine Sales by Regions (2015-2020) (K Units)
Table 112. Global Ketorolac Tromethamine Sales Market Share by Regions (2015-2020)
Table 113. Global Ketorolac Tromethamine Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Ketorolac Tromethamine Sales by Countries (2015-2020) (K Units)
Table 115. North America Ketorolac Tromethamine Sales Market Share by Countries (2015-2020)
Table 116. North America Ketorolac Tromethamine Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020)
Table 118. Europe Ketorolac Tromethamine Sales by Countries (2015-2020) (K Units)
Table 119. Europe Ketorolac Tromethamine Sales Market Share by Countries (2015-2020)
Table 120. Europe Ketorolac Tromethamine Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Ketorolac Tromethamine Sales by Regions (2015-2020) (K Units)
Table 122. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Ketorolac Tromethamine Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Ketorolac Tromethamine Sales by Countries (2015-2020) (K Units)
Table 125. South America Ketorolac Tromethamine Sales Market Share by Countries (2015-2020)
Table 126. South America Ketorolac Tromethamine Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Ketorolac Tromethamine Sales by Countries (2015-2020) (K Units)
Table 129. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Ketorolac Tromethamine Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020)
Table 132. Global Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 133. Global Ketorolac Tromethamine Sales Share by Type (2015-2020)
Table 134. Global Ketorolac Tromethamine Revenue by Type (2015-2020) (USD Million)
Table 135. Global Ketorolac Tromethamine Revenue Share by Type (2015-2020)
Table 136. Global Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 137. Global Ketorolac Tromethamine Sales Share by Application (2015-2020)
Table 138. Global Ketorolac Tromethamine Sales Forecast by Regions (2021-2025) (K Units)
Table 139. Global Ketorolac Tromethamine Market Share Forecast by Regions (2021-2025)
Table 140. Global Ketorolac Tromethamine Sales Forecast by Type (2021-2025) (K Units)
Table 141. Global Ketorolac Tromethamine Market Share Forecast by Type (2021-2025)
Table 142. Global Ketorolac Tromethamine Sales Forecast by Application (2021-2025)
Table 143. Global Ketorolac Tromethamine Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ketorolac Tromethamine Picture
Figure 2. Global Sales Market Share of Ketorolac Tromethamine by Type in 2019
Figure 3. Injection Picture
Figure 4. Ophthalmic Picture
Figure 5. Nasal Picture
Figure 6. Oral tablet Picture
Figure 7. Ketorolac Tromethamine Sales Market Share by Application in 2018
Figure 8. Short-term treatment of pain Picture
Figure 9. Ophthalmic Surgery Picture
Figure 10. Global Ketorolac Tromethamine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Ketorolac Tromethamine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Ketorolac Tromethamine Sales Market Share by Manufacturer in 2019
Figure 31. Global Ketorolac Tromethamine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Ketorolac Tromethamine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Ketorolac Tromethamine Revenue Market Share by Regions in 2018
Figure 39. North America Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
Figure 40. Europe Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
Figure 42. South America Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Ketorolac Tromethamine Sales and Growth Rate (2015-2020)
Figure 44. North America Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Ketorolac Tromethamine Sales Market Share by Countries (2015-2020)
Figure 46. North America Ketorolac Tromethamine Sales Market Share by Countries in 2018
Figure 47. North America Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Ketorolac Tromethamine Revenue Market Share by Countries in 2018
Figure 49. United States Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Ketorolac Tromethamine Revenue Market Share by Countries in 2019
Figure 55. Germany Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Ketorolac Tromethamine Revenue Market Share by Regions 2019
Figure 63. China Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Ketorolac Tromethamine Sales Market Share by Countries in 2019
Figure 70. South America Ketorolac Tromethamine Revenue Market Share by Countries in 2019
Figure 71. Brazil Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Ketorolac Tromethamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Ketorolac Tromethamine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Ketorolac Tromethamine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Ketorolac Tromethamine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Ketorolac Tromethamine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Ketorolac Tromethamine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Ketorolac Tromethamine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Ketorolac Tromethamine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Ketorolac Tromethamine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
プライベート眼科用椅子の世界市場 2020年 Market Overview The global Private Ophthalmic Chair market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Private Ophthalmic C…- シクロスポリン点眼薬の世界市場 2020年 Market Overview The global Cyclosporine Ophthalmic Emulsion market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cyclosporine…
- エキシマ・フェムト秒眼科用レーザーの世界市場 2020年 Market Overview The global Excimer and Femtosecond Ophthalmic Lasers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exc…
- 眼科超音波システムの世界市場 2020年 Market Overview The global Ophthalmic Ultrasound System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmic Ultra…
- 眼科用顕微鏡の世界市場 2020年 Market Overview The global Ophthalmic Microscope market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmic Microscope m…